Project Details
Description
Hepatitis C virus (HCV) infects ~185 million people worldwide; more than 4 million Americans. HCV infection is the most common cause of liver disease (cirrhosis), is the leading indicator for liver transplantation (LT), and is a potent driver of hepatocellular carcinoma (HCC). There are no effective therapies for HCC and 5- year survival is
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/17 → 6/30/21 |
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases: $620,487.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $601,776.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.